Literature DB >> 20445271

Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.

Nipawan Nuemket1, Yoshikazu Tanaka, Kentaro Tsukamoto, Takao Tsuji, Keiji Nakamura, Shunji Kozaki, Min Yao, Isao Tanaka.   

Abstract

Botulinum toxin (BoNT) from Clostridium botulinum OFD05, isolated from bovine botulism, is a D/C mosaic-type BoNT. BoNTs possess binding, translocation and catalytic domains. The BoNT/OFD05 binding domain exhibits significant sequence identity to BoNT/C, which requires a single ganglioside as a binding receptor on neuronal cells, while BoNT/A and BoNT/B require two receptors for specific binding. To determine the binding mechanism of BoNT/OFD05 and its ganglioside receptors on neuronal cells, recombinant BoNT/OFD05 receptor-binding domain has been expressed, purified and crystallized. Native and SeMet-derivative crystals showed X-ray diffraction to 2.8 and 3.1 A resolution, respectively. The crystals belonged to space group P2(1)2(1)2(1).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445271      PMCID: PMC2864704          DOI: 10.1107/S1744309110012182

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Single-wavelength anomalous diffraction phasing revisited.

Authors:  L M Rice; T N Earnest; A T Brunger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-11

2.  Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.

Authors:  S Swaminathan; S Eswaramoorthy
Journal:  Nat Struct Biol       Date:  2000-08

3.  MAGICSQUASH: more versatile non-crystallographic averaging with mulitple constraints.

Authors:  D J Schuller
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-05-01

4.  Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.

Authors:  Kentaro Tsukamoto; Tomoko Kohda; Masafumi Mukamoto; Kumiko Takeuchi; Hideshi Ihara; Masaki Saito; Shunji Kozaki
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

5.  Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.

Authors:  Consuelo Garcia-Rodriguez; Raphael Levy; Joseph W Arndt; Charles M Forsyth; Ali Razai; Jianlong Lou; Isin Geren; Raymond C Stevens; James D Marks
Journal:  Nat Biotechnol       Date:  2006-12-17       Impact factor: 54.908

Review 6.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

Review 7.  Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.

Authors:  E A Johnson; M Bradshaw
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

8.  Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.

Authors:  Kentaro Tsukamoto; Yuiko Kozai; Hideshi Ihara; Tomoko Kohda; Masafumi Mukamoto; Takao Tsuji; Shunji Kozaki
Journal:  Microb Pathog       Date:  2008-01-31       Impact factor: 3.738

Review 9.  Botulinal neurotoxins: revival of an old killer.

Authors:  Cesare Montecucco; Jordi Molgó
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  1 in total

1.  Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .

Authors:  Andrew P-A Karalewitz; Abby R Kroken; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.